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ABSTRACT
Introduction: Functional dyspepsia and non-erosive reflux
disease (NERD) are prevalent gastrointestinal conditions
with accumulating evidence regarding an overlap between
the two. Still, patients with NERD represent a very
heterogeneous group and limited data on dyspeptic
symptoms in various subgroups of NERD are available.
Aim: To evaluate the prevalence of dyspeptic symptoms
in patients with NERD subclassified by using 24 h
impedance-pH monitoring (MII-pH).
Methods: Patients with typical reflux symptoms and
normal endoscopy underwent impedance-pH monitoring off
proton pump inhibitor treatment. Oesophageal acid
exposure time (AET), type of acid and non-acid reflux
episodes, and symptom association probability (SAP) were
calculated. A validated dyspepsia questionnaire was used to
quantify dyspeptic symptoms prior to reflux monitoring.
Results: Of 200 patients with NERD (105 female; median
age, 48 years), 81 (41%) had an abnormal oesophageal
AET (NERD pH-POS), 65 (32%) had normal oesophageal
AET and positive SAP for acid and/or non-acid reflux
(hypersensitive oesophagus), and 54 (27%) had normal
oesophageal AET and negative SAP (functional heartburn).
Patients with functional heartburn had more frequent
(p,0.01) postprandial fullness, bloating, early satiety and
nausea compared to patients with NERD pH-POS and
hypersensitive oesophagus.
Conclusion: The increased prevalence of dyspeptic
symptoms in patients with functional heartburn reinforces
the concept that functional gastrointestinal disorders
extend beyond the boundaries suggested by the
anatomical location of symptoms. This should be regarded
as a further argument to test patients with symptoms of
gastro-oesophageal reflux disease in order to separate
patients with functional heartburn from patients with
NERD in whom symptoms are associated with gastro-
oesophageal reflux.
Gastro-oesophageal reflux disease (GORD) is one
of the most common chronic gastrointestinal
diseases in Western countries.1 2 Recent studies
documented that up to 70% of reflux patients have
typical reflux symptoms (ie, heartburn and/or
regurgitation) in the absence of endoscopically
visible oesophageal mucosal injuries, making non-
erosive reflux disease (NERD) the more common
form of GORD.3 4 The NERD patient group
incorporates subgroups which differ significantly
in terms of presentation, pathophysiology and
management. Patients experiencing typical reflux
symptoms without evidence of oesophagitis on
upper endoscopy are classified on the basis of
oesophageal pH monitoring results and symptom
association analysis as suffering either from NERD,
when excessive acid reflux or a positive symptom
association with acid reflux is demonstrated, or
from functional heartburn (FH), when, in agree-
ment with Rome III criteria, distal oesophageal
acid exposure is normal and a negative response to
acid suppression is found.5 6 Recognising that
stimuli other than acid can evoke typical reflux
symptoms,7 our group previously proposed sub-
classifying patients with typical reflux symptoms
and normal upper gastrointestinal endoscopy as
follows: (1) NERD pH-POS patients with normal
endoscopy and abnormal distal oesophageal acid
exposure; (2) hypersensitive oesophagus – patients
with normal endoscopy, normal distal oesophageal
acid exposure and positive symptom association
for either acid or non-acid reflux; and (3) func-
tional heartburn – patients with normal endo-
scopy, normal distal oesophageal acid exposure and
negative symptom association for acid and non-
acid reflux.8
Patients with GORD, both with erosive oesopha-
gitis and NERD, frequently report dyspeptic symp-
toms.9 Epidemiological studies investigating the
prevalence of dyspeptic and oesophageal symptoms
have reported a higher prevalence of dyspeptic
symptoms in patients with GORD, suggesting that
the degree of overlap is greater than could be
predicted by chance alone.10 Moreover, it was
recently demonstrated that patients with functional
heartburn and poor response to acid suppressive
therapy are more likely to have psychopathology
similarly to patients with functional dyspepsia.11
Last, but not least, abdominal symptoms appear to
be independent predictors of the severity of reflux
symptoms in patients with NERD when compared
to normal controls.12
Given previous reports indicating an inverse
relationship between dyspeptic symptoms and
the objective criteria for GORD we hypothesised
that in patients with functional heartburn dyspep-
tic symptoms should be more prevalent compared
to the rest of NERD patients. To test this
hypothesis, we evaluated the prevalence of dys-
peptic symptoms in patients with NERD subclas-
sified into three distinct groups by using 24 h MII-
pH monitoring.
METHODS
Study subjects
Between June 2004 and September 2008, patients
presenting to the outpatient motility centre at the
Oesophagus
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University of Genoa with predominant typical GORD symp-
toms (ie, heartburn and regurgitation) lasting for more than
6 months and occurring at least three times weekly, were
prospectively enrolled in the study. All subjects who agreed to
participate in our investigation underwent careful history
taking physical and clinical examination, upper gastrointestinal
endoscopy to assess the presence or not of oesophageal mucosal
injury, routine biochemistry, and upper abdominal ultrasound.
The medical history included information on treatment with
acid suppressive medication (in particular proton pump
inhibitors (PPIs)) and symptomatic response to PPI therapy.
Patients reporting >50% symptom improvement were consid-
ered responders to PPI therapy. Patients treated with anti-
secretory drugs were asked to discontinue acid suppressive
therapy at least 30 days before the endoscopic examination.
During the washout period, patients were allowed to use an oral
antacid or alginate on an as-needed basis for the relief of
heartburn. Based on the results of upper endoscopy, patients
were then subdivided into three major groups – Barrett’s
oesophagus, erosive oesophagitis and NERD – in cases where
the typical symptoms of GORD were present, and where visible
oesophageal mucosal injury was absent. Patients with Barrett’s
oesophagus and erosive oesophagitis were not included in the
present study. Within 1–5 days (median 3 days) from the upper
endoscopy, patients with NERD underwent ambulatory com-
bined impedance-pH monitoring. Exclusion criteria were:
history of thoracic, oesophageal or gastric surgery; primary or
secondary severe oesophageal motility disorders (eg, achalasia,
scleroderma, diabetes mellitus, autonomic or peripheral neuro-
pathy, myopathy); underlying psychiatric illness; use of non-
steroidal anti-inflammatory drugs (NSAIDs) and aspirin; pre-
sence of peptic stricture and duodenal or gastric ulcer on upper
endoscopy, evidence of erosive oesophagitis at previous (2–5
years) endoscopy, presence of dyspeptic symptoms as major
symptoms. In women of childbearing age, pregnancy was
excluded by urine analysis. During upper gastrointestinal endo-
scopy, biopsies were taken from the antrum and the corpus for
assessing the presence of Helicobacter pylori. Patients were asked to
discontinue any medication that would influence oesophageal
motor function at least 1 week before administering the
questionnaires and performing tests of oesophageal function.
All participants gave written informed consent before
entering the study.
Symptom questionnaire
Before the 24 h pH-impedance study, each patient completed a
functional dyspepsia questionnaire as reported and validated
previously.13 This questionnaire included questions on the
presence and intensity (range, 0–3; where 0 = absent, 1 = mild,
2 = moderate, and 3 = severe, interfering with daily activities) of
epigastric pain, bloating, postprandial fullness, early satiety,
nausea, vomiting, excessive belching and epigastric burning.
Also, typical GORD symptoms (ie, heartburn and regurgitation)
were evaluated using the same questionnaire (0 = absent,
1 = mild, 2 = moderate, and 3 = severe). A second investigator
completed a structured interview with the patient including a
careful medical history (including height and weight), current
medication, tobacco use and alcohol consumption.
Oesophageal multichannel intraluminal impedance and pH
monitoring
Oesophageal impedance-pH monitoring was performed using
an ambulatory multichannel intraluminal impedance and pH
(MII-pH) monitoring system (Sleuth; Sandhill Scientific,
Highland Ranch, Colorado, USA). The system included a
portable data logger and a catheter with one antimony pH
electrode and eight impedance electrodes at 2, 4, 6, 8, 10, 14, 16
and 18 cm from the tip of the catheter. Each pair of adjacent
electrodes represented an impedance-measuring segment (2 cm
length) corresponding to one recording channel. The six
impedance and one pH signals were recorded at 50 Hz on a
128 MB CompactFlash (SanDisk, Milpitas, California, USA).
The methodology of probe calibration, catheter placement,
patient instruction and performance have been previously
described.8 On the monitoring day, each subject ate three
standard meals of a Mediterranean diet as previously reported.14
The data stored on the CompactFlash card were downloaded
into a personal computer and analysed using a semiautomated
reflux detection algorithm (Autoscan; Sandhill Scientific).
Tracings were subsequently reviewed manually by an expert
reader (ES) in order to ensure accurate detection and classifica-
tion of reflux episodes. Meal periods were excluded from the
analysis.
Definitions of reflux episodes
Simultaneously recorded pH data were used to classify reflux
episodes as acid, weakly acidic, or weakly alkaline according to
the previously reported criteria:15
c Acid reflux: impedance-detected reflux episodes with a nadir
pH less than 4
c Weakly acidic reflux: impedance-detected reflux episodes
with a nadir pH between 4 and 7
c Weakly alkaline reflux: impedance-detected reflux episodes
with a nadir pH above 7. For symptom analysis, weakly
acidic and weakly alkaline reflux were grouped together as
non-acid reflux episodes (nadir pH.4)
Gastro-oesophageal reflux parameters
Impedance and pH data were used to determine the number
and type of reflux episodes and distal oesophageal acid exposure
(reflux time (min) and reflux per cent time) in each patient.
Total 24 h oesophageal acid exposure (%) was defined as the
total time when the pH was below 4 divided by the time of
monitoring. A total distal oesophageal acid exposure (ie, per
cent time at pH ,4) of less than 4.2% over 24 h was considered
normal.8 14
Symptom–reflux association analysis
In each patient we calculated the symptom association
probability (SAP) for typical oesophageal symptoms. In the
analysis we separated symptoms associated with acid reflux
from those associated with non-acid reflux (including weakly
acidic and weakly alkaline reflux as a whole) and symptoms
occurring independent of reflux episodes. Separate analysis was
performed for each individual symptom if patients recorded
different types of symptoms.
The SAP was calculated for acid and non-acid reflux using a
custom made Excel macro function (RT). The algorithm
counted the number of symptoms preceded by a reflux episode
within 2 min (S+R+). The number of symptoms not associated
with reflux (S+R2) was calculated by subtracting S+R+ from
the total number of symptoms. The study was divided into 2-
min segments in order to determine the number reflux
containing segments (R+) and reflux-free symptoms (R2).
The two other cells of the 262 contingency table (S2R2 and
S2R+) were calculated by performing the corresponding
Oesophagus
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subtractions. A two-sided Fisher exact test was used to calculate
the probability (p) that the observed distribution could have
been occurred by chance. SAP was calculated as (12p)6100%
and was considered to be positive when >95% was positive.8
Statistical analysis
Continuous variables were compared using ANOVA (with post
hoc comparisons between groups) or the Kruskal–Wallis test
depending on the normal or abnormal distribution of data
(assessed by the Kolmogorov–Smirnov test). The x2 test was
used when comparing categorical variables (ie, the presence/
absence of Helicobacter pylori infection and individual dyspeptic
symptoms). Differences were considered statistically significant
when p,0.05.
RESULTS
Two hundred and sixty-six patients with typical symptoms of
GORD met the enrolment criteria and entered the study. Based
on the results of upper endoscopy, eight patients had Barrett’s
oesophagus, 44 had erosive oesophagitis, and 214 had NERD.
Patients with Barrett’s oesophagus and erosive oesophagitis
were not included in the present study. Of the patients with
NERD, 200 (105 females, mean age 48 years, range 18–78)
reported at least one type of typical gastro-oesophageal reflux
symptom during the monitoring period and were included in
the final analysis. Thirty-four patients (17%) never received PPIs
(‘‘PPI naive’’ NERD patients). Combined impedance-pH mon-
itoring was well tolerated by all subjects and no important
technical failure occurred. The median total recording time was
23.4 h (range 22.9–23.6 h).
Acid exposure and symptom association
Acid exposure time and symptom association probability is
shown in fig 1. Patients with NERD were subdivided into four
different subgroups according to oesophageal acid exposure and
symptom association. We found an abnormal distal oesophageal
acid exposure time in 81 (41%) patients, 71 (36%) of whom had
a positive SAP (NERD pH-POS/SAP+) and 10 (5%) had no
Figure 1 Subclassification of patients
with non-erosive reflux disease (NERD),
based on distal oesophageal acid
exposure and symptom association in
NERD pH-POS (abnormal per cent time
the pH was ,4), hypersensitive
oesophagus (normal per cent time pH ,4
and positive symptom association
probability (SAP), and functional
heartburn (normal per cent time the pH
was ,4, and negative SAP).
Table 1 Demographic and clinical characteristics, treatment with proton pump inhibitors (PPIs), and treatment response of patients with non-erosive
reflux disease (n = 200)
Demographic or clinical parameter pH-POS/SAP+ pH-POS/SAP2 pH-NEG/SAP+ pH-NEG/SAP2 p Value
Patients, no 71 10 65 54
Female patients, no 29 4 35 37 ,0.01
Patients with clinically relevant dyspeptic symptoms, no 26 4 24 34 ,0.01
Mean age, years (range) 50.7 (20–78) 51.9 (34–76) 46.1 (22–77) 45.8 (18–76) NS
Mean body mass index (range) 26.7 (18–42) 27.3 (20–38) 23.5 (19–41) 22.9 (16–34) ,0.01
Tobacco use, % 21.1 30.0 23.1 25.9 NS
Alcohol consumption, % 40.8 40.0 33.8 35.2 NS
Coffee consumption, % 80.3 80.0 73.8 77.8 NS
Prevalence of hiatal hernia, % 76.1 80.0 43.1 42.6 ,0.01
Prevalence of Helicobacter pylori infection, % 8.5 10.0 9.2 9.3 NS
Patients having previously received PPIs, no (%) 46 (65) 6 (60) 62 (95) 52 (96) ,0.01
Positive (>50%) symptom response, no (%) 34 (74) 4 (67) 33 (53) 15 (29) ,0.01
NEG, negative; POS, positive; SAP, symptom association probability.
Oesophagus
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association between symptoms and any type of reflux (NERD
pH-POS/SAP2). One hundred and nineteen patients (59%) had
a normal distal oesophageal acid exposure (per cent time pH ,4
less than 4.2%), 65 (32%) of whom had a positive SAP (NERD
pH-NEG/SAP+; hypersensitive oesophagus subgroup). Fifty-
four (27%) patients had no association between symptoms
and any type of reflux (NERD pH-NEG/SAP2; functional
heartburn subgroup).
Demographic and clinical characteristics
Detailed demographic and clinical characteristics of the various
subgroups of patients with NERD are shown in table 1. There
were no differences with respect to age, smoking, alcohol, coffee
consumption and prevalence of H pylori infection (p = NS). The
prevalence of hiatal hernia was higher in NERD pH-POS
patients with positive SAP and negative SAP compared to those
with hypersensitive oesophagus or FH (76.1 vs 80 vs 43.1 vs
42.6; p,0.01). Moreover, patients in the NERD pH-POS
subgroups had a higher mean body mass index than patients
with hypersensitive oesophagus or FH (26.7 vs 27.3 vs 23.5 vs
22.9; p,0.01). Finally, patients of the functional heartburn
subgroup were more frequently women than those in the other
two subgroups (40 vs 40.8 vs 53.8% vs 68.5; p,0.01).
Typical GORD symptoms in different subgroups of patients with
NERD
Patients with NERD had a median heartburn score of 2 (range 1–3)
and a median regurgitation score of 2 (range 0–3) recorded in the
GORD symptoms questionnaires. Details on the number and
percentages of patients on PPIs and the numbers and percentages
of patients who responded to PPIs are shown in table 1.
Symptoms reported during the study day were in agreement
with the symptom questionnaires. Indeed, 66 (93%) patients with
NERD pH-POS/SAP+ (median heartburn score 2), eight (80%)
with NERD pH-POS/SAP2 (median heartburn score 2), 58 (89%)
NERD pH-NEG/SAP+ (median heartburn score 2) and 50 (93%)
NERD pH-NEG/SAP2 (median heartburn score 2) reported
heartburn, while 43 (61%) patients with NERD pH-POS/SAP+
(median regurgitation score 2), five (50%) with NERD pH-POS/
SAP2 (median regurgitation score 2), 36 (55%) NERD pH-NEG/
SAP+ (median regurgitation score 2) and 18 (33%) NERD pH-
NEG/SAP2 (median regurgitation score 1) reported regurgitation.
The total number of symptoms reported by patients with
NERD was 2245 (mean 4.5, range 1–69). Patients reported 1465
heartburn events (mean 10, range 1–62) and 780 regurgitation
episodes (mean 9, range 1–69). Data on the number of
heartburn and regurgitation events reported by patients in
various subgroups of NERD are summarised in fig 2A,B.
Figure 2 (A) Percentages of patients reporting typical symptoms of gastro-oesphageal reflux disease (GORD) stratified according to the results
(n = 200) of 24 h impedance-pH monitoring. (B) Mean numbers of GORD symptoms stratified according to the results (n = 200) of 24 h impedance-pH
monitoring. NEG, negative; POS, positive; Pts, patients; SAP, symptom association probability.
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Dyspepsia symptoms in different subgroups of patients with
NERD
As summarised in fig 3A, in the FH subgroup symptoms such as
nausea, postprandial fullness, early satiety and bloating were
more frequent compared to NERD pH-POS patients with both
positive and negative SAP and those with hypersensitive
oesophagus (p,0.01). Epigastric pain and epigastric burning
tended to be more frequent in patients of NERD pH-POS with
positive SAP and negative SAP subgroups, but statistical
significance was not reached (p = NS). Similar results were
obtained when considering only moderate/severe dyspeptic
symptoms (severity score >2), as shown in fig 3B.
DISCUSSION
Upper gastrointestinal symptoms are remarkably common in the
general population, with the majority of patients having GORD
or dyspepsia.10 16 Periodically updated international criteria,
applying standardised questionnaires for symptom collection,
have led to the classification of patients into distinct disease
categories (currently, Rome III). Patients suffering from sympto-
matic heartburn and/or regurgitation are clinically classified as
GORD – in the absence of oesophageal mucosa abnormalities as
NERD – and not dyspepsia. In functional gastrointestinal
disorders, however, a certain degree of overlapping symptoms
has been reported,17–20 and this degree of overlap appears to be
greater than would be predicted by chance alone.
Non-erosive or negative-endoscopy reflux disease (NERD)
may account for up to 70% of patients with GORD in the
community.8–10 NERD is a heterogeneous disorder and incorpo-
rates subgroups which differ significantly in terms of presenta-
tion, pathophysiology and management. Because of this
heterogeneity, previous studies tried to differentiate NERD
patients on the basis of acid exposure on 24 h pH studies.
However, this differentiation left some difficulties in distin-
guishing patients with true reflux disease from those with
functional disease, reducing the possibility to evaluate the
degree of overlap between NERD and functional dyspepsia or
functional disorders as a whole. Recently, recognising that
stimuli other than acid can evoke typical reflux symptoms,7 we
have proposed subclassifying patients with NERD by using the
combination of conventional pH with oesophageal intraluminal
electrical impedance monitoring, in order to distinguish these
patients more clearly on the basis of their distal oesophageal
acid exposure or positive and/or negative symptom association
to acid or non-acid reflux during the MII-pH recording.
Applying this technique to the NERD population in current
study, we reduced the proportion of patients who would have
been previously labelled as presenting with FH as follows: (1)
41% as NERD pH-POS patients; (2) 32% as hypersensitive
oesophagus patients; and (3) 27% as functional heartburn
patients. These percentages are in agreement with those of a
previous study in which we assessed 150 patients with NERD
recruited in three Italian centres.8
In our study, prospectively collected 24 h ambulatory
impedance-pH monitoring data and functional dyspepsia
questionnaires in a large group of unselected NERD patients
off PPI treatment led us to show that clinically relevant
dyspeptic symptoms are present in 44% of the NERD
population, in accordance with other investigations.18
Moreover, to our knowledge, this is the first study assessing
in a large group of patients with NERD, off medication, the
distribution of typical GORD and dyspepsia symptoms to
evaluate the degree of overlap between functional dyspepsia and
the different subgroups of the NERD population identified by
means of MII-pH monitoring. In particular, we showed that
subclassifying NERD patients into three different groups on the
basis of 24 h pH-impedance results, dyspeptic symptoms are
more frequently reported in patients with FH (63%) compared
to the NERD pH-POS/SAP+ (37%), NERD pH-POS/SAP2
(36.6%) and hypersensitive oesophagus (37%) subgroups,
suggesting a significantly different degree of overlap of NERD
subgroups with functional dyspepsia.
Patients now diagnosed with FH from the NERD collective
reported much more frequently dyspeptic symptoms such as
postprandial fullness, bloating, early satiety and nausea
compared to the NERD pH-POS with positive SAP and negative
SAP and hypersensitive oesophagus subgroups. In particular,
postprandial fullness and early satiation were the main
symptoms more frequently related to the FH subgroup,
suggesting a possible association between this disorder and the
post prandial distress syndrome, as defined by Rome III
criteria.17 21 The same proportions in symptom prevalence were
maintained when considering moderate/severe dyspeptic symp-
toms, and this further corroborates the fact that dyspeptic
symptoms have a different prevalence among the various
subgroups of NERD patients we identified by means of MII-
pH. Moreover, we found that symptoms such as epigastric pain
and epigastric burning were more frequently encountered in
NERD pH-POS with positive SAP and negative SAP patients,
thus confirming previous controlled studies showing that
epigastric pain syndrome is more prevalent in patients with
abnormal pH test.22 This is in keeping with findings from
controlled studies showing that NERD patients with a positive
pH-metry are more likely to respond to proton pump inhibitor
treatment, similarly to dyspeptic patients with predominant
pain.23 Finally, the presence of a different distribution of
dyspepsia symptoms in our patients confirms the existence of
two different clinical dyspepsia patterns as assessed in the last
Rome III consensus and here for the first time validated in a
large group of NERD patients.
Moreover, if we look at the prevalence of typical reflux
symptoms in our population, we found that NERD pH-POS
with positive SAP and negative SAP patients more often
experienced regurgitation episodes than did patients with FH,
with an increasing frequency during the recording period,
suggesting that they have a GORD symptom pattern more
similar to that of patients with erosive oesophagitis and
Barrett’s oesophagus than with FH.1–4 The percentages of
patients reporting heartburn were similar in our subgroups,
but patients with FH reported more frequently heartburn
during the monitoring. This certainly could have been
influenced by psychosocial factors as suggested by Watson et
al.11 Unfortunately, in the current study, psychological profiles
were not collected in all patients. While available data (results
not shown) indicating more frequently anxiety and/or depres-
sion in the FH patient group are consistent with recently
published data on functional dyspepsia by van Odenhove et al,24
we are deferring further conclusions to an adequately designed
and powered study evaluating the contribution of psychology
features in symptom generation in patients with functional
oesophageal disorders.
Finally, some demographic features were different in our
subgroups. We found that NERD pH-POS patients indepen-
dently of the symptom association were more frequently male,
had a higher mean body mass index and an increased prevalence
of hiatal hernia, in agreement with those studies considering
these demographic and clinical parameters as risk factors for the
Oesophagus
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Figure 3 (A) Prevalence of dyspeptic symptoms (score .0) in patients with non-erosive reflux disease (NERD) subclassified using impedance-pH
monitoring (n = 200). (B) Prevalence of moderate/severe dyspeptic symptoms (score >2) in patients with NERD subclassified using impedance-pH
monitoring (n = 200). NEG, negative; POS, positive; SAP, symptom association probability.
Oesophagus
1190 Gut 2009;58:1185–1191. doi:10.1136/gut.2008.175810
development of GORD and, particularly, abnormal pH mon-
itoring.10 25–27 These features may help to identify patients with
NERD and with an abnormal pH-impedance monitoring.
Moreover, we demonstrated a higher prevalence of female
gender in the FH subgroup, as it has been reported in the
functional dyspepsia population and generally in patients with
functional disorders.17 28–30 No differences based on age, tobacco
use, alcohol and coffee consumption, prevalence of H pylori
infection could be demonstrated in our population. This is in
agreement with various studies20 27 showing that these factors
are not peculiar of anyone of our subgroups.
One limitation of our study is the lack of outcome
prospective data as no information on the response to a
standardised therapeutic approach in the described patient
groups are currently available. However, considering the
previous response to PPI treatment referred to by the majority
of our patients before entering the study we can argue that
patients with abnormal distal oesophageal acid exposure and/or
positive symptom association and dyspeptic symptoms do
respond better to antisecretive treatment compared to patients
with negative symptom association and dyspeptic symptoms.
Evaluating patients on a Mediterranean diet could also be
regarded as a shortcoming of the present study with the
argument that it was not refluxogenic enough to induce
symptoms. While being cognisant of this problem we chose
the Mediterranean diet in order to be able to compare the results
in patients with NERD with those collected in healthy Italian
volunteers and, on the other hand, trying to minimise diet-
induced variation in the amount of gastro-oesophageal reflux.
Last, but not least, the 30 day washout period before the upper
endoscopy in patients using acid suppressive medication could
have been too short for lesions to develop. Still, in our
experience, this represents the maximum we can ask of patients
in order to obtain good compliance and without them dropping
out from the study. Moreover, the incidence of recurring erosive
lesions after a shorter period of PPI cessation remains unknown.
In conclusion, the present study underscores the important
overlap between functional dyspepsia and NERD. This argues
for the need to monitor dyspeptic symptoms and both acid and
non-acid reflux episodes in patients primarily diagnosed with
NERD to help identify the proportion of patients with true FH,
who should, preferably, be included in the overall population
with functional gastrointestinal disorders and should not be
considered as a GORD subgroup any more. We believe this
deliberate separation would spare these patients from wasteful
and protracted courses of years of acid suppression and, above
all, prevent potentially disastrous exposure to surgical options.
Prospective outcome data are now needed to show the clinical
significance of these findings in respect of future definition of
NERD. Of particular interest would be the prospective
evaluation of the response to acid suppressive therapy of
NERD pH-POS and NERD pH-NEG/SAP+ for acid patients
against NERD pH-NEG/SAP+ for non-acid and the response to
reflux reducing therapies of NERD pH-POS and NERD pH-
NEG/SAP+ for acid and non-acid patients against NERD pH-
NEG/SAP2 patients. This possible redefinition as suggested in
the present manuscript might impact upon the epidemiology,
pathophysiology and natural history of the respective disorders.
Competing interests: None.
Ethics approval: The study protocol was approved by the local Ethics Committees in
November 2003 and was performed according to the Declaration of Helsinki.
REFERENCES
1. Kahrilas PJ. Gastroesophageal reflux disease. JAMA 1996;276:983–8.
2. Spechler SJ. Epidemiology and natural history of gastroesophageal reflux disease.
Digestion 1992;51(Suppl 1):24–9.
3. Smout AJPM. Endoscopy-negative acid reflux disease. Aliment Pharmacol Ther
1997;11(Suppl 2):81–5.
4. Lind T, Havelund T, Carlsson R, et al. Heartburn without esophagitis: efficacy of
omeprazole therapy and features determining therapeutic response.
Scand J Gastroenterol 1997;32:974–9.
5. Fass R, Fennerty MB, Vakil N. Non-erosive reflux disease (NERD) – current concepts
and dilemmas. Am J Gastroenterol 2001;96:303–14.
6. Galmiche JP, Clouse RE, Balint A, et al. Functional esophageal disorders.
Gastroenterology 2006;130:1459–65.
7. Fass R, Naliboff B, Higa L, et al. Differential effect of long-term esophageal acid
exposure on mechano-sensitivity and chemo-sensitivity in humans. Gastroenterology
1998;115:1363–73.
8. Savarino E, Zentilin P, Tutuian R, et al. The role of non-acid reflux in NERD – Lessons
learned from impedance-pH monitoring in 150 patients off therapy. Am J Gastroenterol
2008;103:2685–93.
9. Justin C, Wu Y, Carrian M, et al. Distinct clinical characteristics between patients
with nonerosive reflux disease and those with reflux esophagitis. Clin Gastroenterol
Hepatol 2007;5:690–5.
10. Locke GR, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastro-
esophageal reflux: a population-based study in Olmstead County, Minnesota.
Gastroenterology 1997;112:1448–56.
11. Watson RGP, Tham TCK, Johnston BT, et al. Double blind cross-over placebo
controlled study of omeprazole in the treatment of patients with reflux symptoms and
physiological levels of acid reflux – the ‘sensitive oesophagus’. Gut 1997;40:587–90.
12. Zimmerman J, Hershcovici T. Bowel symptoms in non-erosive gastroesophageal
reflux disease: nature, prevalence and relation to acid reflux. J Clin Gastroenterol
2008;42:261–5.
13. Tack J, Caenepeel P, Fischler B, et al. Hypersensitivity to gastric distention is
associated with symptoms in functional dyspepsia. Gastroenterology
2001;121:526–35.
14. Zentilin P, Iiritano E, Dulbecco P, et al. Normal values of 24-h ambulatory intraluminal
impedance combined with pH-metry in subjects eating a Mediterranean diet. Dig Liv
Dis 2006;38:226–32.
15. Sifrim D, Castell D, Dent J, et al. Gastro-oesophageal reflux monitoring: Review and
consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut
2004;53:1024–31.
16. Talley NJ, Zinsmeister AR, Schleck CD, et al. Dyspepsia and dyspepsia subgroups: a
population-based study. Gastroenterology 1992;102:1259–68.
17. Quigley EM. Functional dyspepsia (FD) and non-erosive reflux disease (NERD):
overlapping or discrete entities? Best Pract Res Clin Gastroenterol 2004;18:695–706.
18. Tack J, Caenepeel P, Arts J, et al. Prevalence of acid reflux in functional dyspepsia
and its association with symptom profile. Gut 2005;54:1370–6.
19. Corsetti M, Caenepeel P, Janssens J, et al. Impact of coexisting irritable bowel
syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia.
Am J Gastroenterol 2004;99:1152–9.
20. Sarnelli G, De Giorgi F, Efficie E, et al. Correlation between oesophageal acid
exposure and dyspeptic symptoms in patients with nonerosive reflux disease.
Eur J Gastroenterol Hepatol 2008;20:264–8.
21. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders.
Gastroenterology 2006;130:1466–79.
22. Talley NJ, Meineche-Schmidt V, Pare P, et al. Efficacy of omeprazole in functional
dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera
studies). Aliment Pharmacol Ther 1998;12:1055–65.
23. Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured
questionnaire in the assessment of symptomatic gastroesophageal reflux disease.
Scand J Gastroenterol 1998;33:1023–9.
24. Van Oudenhove L, Vandenberghe J, Geeraerts B, et al. Determinants of symptoms
in functional dyspepsia: gastric sensorimotor function, psychosocial factors or
somatisation? Gut 2008;57:1666–73.
25. Friedenberg FK, Xanthopoulos M, Foster GD, et al. The association between
gastroesophageal reflux disease and obesity. Am J Gastroenterol
2008;103:2111–22.
26. Pandolfino J. The relationship between obesity and GERD: ‘‘big or overblown’’.
Am J Gastroenterol 2008;103:1355–7.
27. Labenz J, Jaspersen J, Kulig M, et al. Risk factors for erosive esophagitis; a
multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol
2004;99:1652–6.
28. Bolling-Strenevald E, Carlsson R, Aalykke C, et al. Self-administered symptom
questionnaires in patients with dyspepsia and their yield in discriminating between
endoscopic diagnoses. Dig Dis 2002;20:191–8.
29. Wele´n K, Faresjo¨ A, Faresjo¨ T. Functional dyspepsia affects women more than men
in daily life: a case–control study in primary care. Gend Med 2008;5:62–73.
30. Flier SN, Rose S. Is functional dyspepsia of particular concern in women? A review
of gender differences in epidemiology, pathophysiologic mechanisms, clinical
presentation, and management. Am J Gastroenterol 2006;101(Suppl 12):S644–53.
Oesophagus
Gut 2009;58:1185–1191. doi:10.1136/gut.2008.175810 1191
